Accelus closes $20 million debt facility with Symbiotic Capital

By Marisa Wong

Los Angeles, Jan. 18 – Accelus obtained a $20 million debt facility from Symbiotic Capital, according to a press release.

The financing is intended to strengthen the company’s balance sheet, as well as to support its expansion and to accelerate its clinical research and product development efforts.

Piper Sandler acted as the company’s financial adviser.

Accelus is a privately held medical technology company based in Palm Beach Gardens, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.